Deltex Medical Group plc is in the April edition of the British Journal of Anaesthesia

Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), announced today that it intends to release its results for the year ended 31 December 2017 on 9 May 2018.

Further to the announcement of the online publication of the results of the FEDORA trial on 1 March 2018, the Company notes that the study was included in the April print edition of the British Journal of Anaesthesia.

A recorded lecture on the FEDORA trial by Professor Monty Mythen is available at no charge at https://www.topmedtalk.com/journal-club-the-fedora-trial/

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Deltex Medical Group Plc

    More articles like this

    Enteq Technologies plc

    Understanding Methane Capture

    Since the advent of the industrial revolution, man has continued to explore distinct ways of fulfilling energy needs. One of these techniques heavily relied upon is the extraction and burning of fossil fuels, an activity largely

    hVIVO plc

    Hvivo expects Continued Growth with Record Year in 2023

    Hvivo, a pharmaceutical services company formerly known as Open Orphan, said it remained on track to hit its future growth targets after another record year in 2023. The company is set to begin paying annual dividends,